Jump to content

Kastus: Difference between revisions

From Wikipedia, the free encyclopedia
Content deleted Content added
mNo edit summary
No edit summary
Line 34: Line 34:


==History==
==History==
Kastus was founded in 2013 in Dublin following 10 years of collaborative research between the Centre for Research in Engineering Surface Technology (CREST) and [[Dublin Institute of Technology]] funded by Kastus CEO John Browne. <ref>{{cite web
Kastus was founded in 2013 in Dublin following 10 years of collaborative research with [[Dublin Institute of Technology]] funded by Kastus CEO John Browne. <ref>{{cite web
|url= https://www.irishtimes.com/news/health/irish-based-scientists-make-superbug-breakthrough-1.2619315
|url= https://www.irishtimes.com/news/health/irish-based-scientists-make-superbug-breakthrough-1.2619315
|title= Irish based scientists make superbug breakthrough
|title= Irish based scientists make superbug breakthrough

Revision as of 14:43, 25 June 2018

Kastus Technologies
IndustryNanotechnology
Founded2013
FounderJohn Browne
Headquarters
Dublin
,
Republic of Ireland
Area served
Worldwide
ProductsAntimicrobial solutions
Websitewww.kastus.com

Kastus Technologies is a nanotechnology company which specializes in patented visible light activated, photocatalytic, antimicrobial coatings and additives. Founded in Dublin in 2013, Kastus’ antimicrobial coatings and additives have been in development for over 10 years as part of a collaboration with Dublin Institute of Technology.[1][2]

Kastus’ Log4+ product is proven to prevent the growth of any harmful bacteria on the surface it has been applied to, with no toxic additives or negative side effects. Log4+ can be applied to a range of materials, such as ceramics, glass, metals and plastics, in the final stage of production with 0% interruption to the final product.[3] [4][5]

History

Kastus was founded in 2013 in Dublin following 10 years of collaborative research with Dublin Institute of Technology funded by Kastus CEO John Browne. [6] Development on the solution began as early as 2005, with the research being led by Dr. Suresh Pillai and Dr. Brendan Duffy. In 2011, they exhibited tiles which had been treated with their solution at the first European Innovation Convention where their research was chosen as one of 50 star projects from over 450 entries.[7]

Kastus was originally developed in response to government, industry & healthcare requests to help reduce the spread of antibiotic-resistant infections, specifically those caused by bacteria and fungus surviving on surfaces and indoor environment. In October 2017, The Department of Health published “Ireland’s National Action Plan on Antimicrobial Resistance 2017-2020”, which highlighted the threat antimicrobial resistance poses and the urgent need for new technology to combat this.[8]

In April 2016, Kastus’ team of scientists made a significant breakthrough in antimicrobial technology.[9] [10] This research was supported by a €1.5 million funding investment from Atlantic Bridge.[11] [12]

In January 2017, Kastus officially launched its flagship product at Arab Health in Dubai —the largest healthcare event in the MEMA region. This product, commonly referred to as Log4+, is a patented and novel light-activated product that is 99.99% effective at killing superbugs or inhibiting their growth on surfaces which come into frequent human contact.[13]

File:Kastus solution.png
A graphic demonstration of how Kastus' solution prevents the growth of bacteria on surfaces.

In March 2017, Kastus was awarded the Spin-out Company Impact Award. The Knowledge Transfer Impact Award is awarded for substantial commercial achievements by knowledge transfer professionals who work in higher education and publicly-funded research organizations. Kastus was recognized for having achieved a “successful and significant event” in the previous calendar year. [14]

In October 2017, Kastus was the recipient of The Irish Times Innovation Award Overall Prize 2017. One of the most prestigious awards in Irish business. Kastus also picked up the Life Science and Healthcare category award In October 2017, the company launched Kastus Metals at Med In Ireland – Ireland’s largest medical technologies event.[15]

In November 2017, Kastus signed a deal with British Ceramic Tile (BCT), the largest ceramics and glass tiles manufacturer in the UK to put superbug resistant floor and wall tiles on the market in 2018. [16]

References

  1. ^ O'Connor, Ruth (2017-09-08). "Inside Track: Kastus founder John Browne". The Irish Times. Retrieved 2018-04-11.
  2. ^ "Kastus". www.enterprise-ireland.com. Enterprise Ireland. January 1, 2017. Retrieved April 18, 2018.
  3. ^ Leyland, Nigel; et al. (2016-04-21). "Highly Efficient F, Cu doped TiO2 anti-bacterial visible light active photocatalytic coatings to combat hospital-acquired infections". Nature. 6. doi:10.1038/srep24770. Retrieved 2018-04-11. {{cite journal}}: Explicit use of et al. in: |last1= (help)
  4. ^ Brian Hutton (April 22, 2016). "Irish scientists' breakthrough in battle against superbugs". The Irish Mirror. Retrieved May 18, 2018.
  5. ^ Synott, Damian; et al. (February 7, 2013). "Anti-bacterial activity of indoor light activated photocatalysts". Applied Catalysis B: Environmental. 130–131: 106–111. doi:10.1016/j.apcatb.2012.10.020. Retrieved June 13, 2018. {{cite journal}}: Explicit use of et al. in: |first= (help)
  6. ^ Staff Writer (April 21, 2016). "Irish based scientists make superbug breakthrough". The Irish Times. Retrieved April 11, 2018.
  7. ^ Staff Writer (December 1, 2011). "Irish antibacterial tiles selected as star EU-funded research and innovation project at Innovation Convention Expo". Enterprise Ireland. Retrieved June 13, 2018.
  8. ^ Department of Health (October 2017). Ireland’s National Action Plan on Antimicrobial Resistance 2017-2020 (PDF) (Report). Department of Health. Retrieved 25 June 2018.
  9. ^ McMahon, Conor (June 3, 2017). "An Irish med-tech firm could make your smartphone and toilet 'superbug'-free". The Journal. Retrieved May 18, 2018.
  10. ^ Staff Writer (April 21, 2016). "Irish discovery could stem spread of 'superbugs'". RTE. Retrieved April 11, 2018.
  11. ^ O'Brien, Ciara (December 1, 2016). "Tech firm Kastus gets €1.5m investment led by Atlantic Bridge fund". The Irish Times. Retrieved April 11, 2018.
  12. ^ "DIT Hothouse spinout Kastus has raised €1.5m investment as it seeks to boost international sales of its antimicrobial technology to control superbugs". www.dit.ie. Dublin Institute of Technology. December 1, 2016. Retrieved April 11, 2018.
  13. ^ Hoare, Padraig (January 31, 2018). "Irish tech firm Kastus unveils superbug solution". The Irish Examiner. Retrieved April 11, 2018.
  14. ^ Staff Writer (March 30, 2017). "Kastus Wins SpinOut KTI Impact Award". Biz Plus. Retrieved April 11, 2018.
  15. ^ McAleer, Michael (October 11, 2017). "Superbug killer Kastus wins overall prize at Irish Times innovation awards". The Irish Times. Retrieved April 11, 2018.
  16. ^ Kelly, Louise (October 29, 2017). "Irish tech firm Kastus partners with major UK group to create superbug-resistant tiles". The Irish Independent. Retrieved April 11, 2018.